Trade

Windlas Biotech share price

Balanced risk
  • 35%Low risk
  • 35%Moderate risk
  • 35%Balanced risk
  • 35%High risk
  • 35%Extreme risk
  • 803.75(-5.39%)
    January 20, 2026 15:57:20 PM IST
    • NSE
    • BSE
  • Vol : 40.96 K (NSE + BSE)
    Last 20 day avg : 44.76 K

Windlas Biotech is trading -5.39% lower at Rs 803.75 as compared to its last closing price. Windlas Biotech has been trading in the price range of 843.00 & 802.20. Windlas Biotech has given 7.30% in this year & 13.50% in the last 5 days. The company posted a net profit of 17.80 Crores in its last quarter.Listed peers of Windlas Biotech include Sun Pharmaceutical Industries (-3.68%), Cipla (-0.73%), Torrent Pharmaceuticals (-2.72%).The Mutual Fund holding in Windlas Biotech was at 6.63% in 31 Dec 2025. The MF holding has increased from the last quarter. The FII holding in Windlas Biotech was at 0.93% in 31 Dec 2025. The FII holding has decreased from the last quarter.

  • Overview
  • Financials
  • Forecast
  • Technical Analysis
  • Peers
  • Shareholding
  • About the company
  • FAQ

Overview

  • 1 D
  • 5 D
  • 1 M
  • 3 M
  • 6 M
  • 1 Y
  • 5 Y
  • MAX
Explore on
Loading...
Key Metrics

Updated on Jan 21, 2026, 01:41 AM UTC

  • Beta
    Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
    0.58
    Low volatility
  • Dividend Yield
    Annual dividends as a percentage of the stock price.
    0.68
    Lower than industry
  • PEG Ratio
    The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
    1.70
    Indicates Fair Valuation
  • P/E
    Price-to-earnings ratio based on trailing 12-month earnings
    -
  • P/B
    The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
    -
  • Debt To Equity
    The debt-to-equity ratio, indicating a company's financial leverage.
    -
Price range
Day Range
Lowest
802.20
Highest
843.00
52 week range
Lowest
667.30
Highest
1,137.60
Windlas Biotech Peers
Return Comparison
Peers Comparison
Names
Technical ratingPrice%ChangeMarket CapP/EP/BDividend YieldDebt to Equity
Sun Pharmaceutical Industries
Bearish
1,612.00-3.683,86,763.6836.245.770.920.50
Cipla
Bearish
1,381.00-0.731,11,971.8122.953.870.870.81
Torrent Pharmaceuticals
Bullish
3,979.60-2.721,34,523.2767.3217.10.8317.62
Dr Reddy's Laboratories
Bearish
1,166.900.0497,388.4618.633.140.632.34
Divi's Laboratories
Bearish
6,005.80-2.211,59,524.7478.6111.520.460.01
Mutual Fund Ownership
View all
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Growth
NA
  • Amount Invested (Cr.) 78.25
  • % of AUM 1.42
UTI Healthcare Fund Regular Plan Growth
NA
  • Amount Invested (Cr.) 13.80
  • % of AUM 1.30
ICICI Prudential Smallcap Fund Growth
2/5
  • Amount Invested (Cr.) 33.50
  • % of AUM 0.41
ICICI Prudential Smallcap Fund Institutional Growth
3/5
  • Amount Invested (Cr.) 33.50
  • % of AUM 0.41
Bandhan BSE Healthcare Index Fund Regular Growth
NA
  • Amount Invested (Cr.) 0.02
  • % of AUM 0.06
Windlas Biotech Corporate Actions
View all
  • Board Meetings
  • AGM
  • Dividends
  • Bonus
  • Split
  • Rights
Meeting DatePurpose
2025-11-06Quarterly Results
2025-08-12Quarterly Results
2025-05-22Audited Results & Final Dividend
2025-02-11Quarterly Results
2024-11-12Quarterly Results
About the company Windlas Biotech
  • IndustryBiotechnology & Drugs
  • ISININE0H5O01029
  • BSE Code543329
  • NSE CodeWINDLAS
Windlas Biotech Limited is a domestic pharmaceutical formulations contract development and manufacturing organization (CDMO). Its portfolio of CDMO solutions includes product development, licensing, and commercial manufacturing of complex drugs and dosage forms. Its product development and manufacturing capabilities in complex generic products by developing products, including alternate dosages, such as, medicated mouth sprays; coating technologies, including, pellet coating using bottom spray, API coating, pH dependent coating and nanosized crystals; nutraceuticals dosages, including, biscuits, protein powder, supplements, chocolate bars and malt based foods, and ayurvedic products, such as wellness products, hair oils and cough syrups. Its four fungible, Schedule-M compliant OSD/OLD manufacturing facilities are located in Dehradun, Uttarakhand, India. It specializes in manufacturing formulations, solid pharmaceutical dosage forms, liquid pharmaceutical dosage forms and injectables.
  • Management Info
No Data
Management info for Windlas Biotech is currently unavailable
Please check back later.
Windlas Biotech Share Price FAQs

Windlas Biotech is trading at 803.75 as on Tue Jan 20 2026 10:27:20. This is -5.39% lower as compared to its previous closing price of 849.50.

The market capitalization of Windlas Biotech is 1703.89 Cr as on Tue Jan 20 2026 10:27:20.

The 52 wk high for Windlas Biotech is 1137.60 whereas the 52 wk low is 667.30

Windlas Biotech can be analyzed on the following key metrics -

  • TTM P/E: 28.26
  • Sector P/E: -
  • Dividend Yield: 0.68%
  • D/E ratio: 0.06

Windlas Biotech reported a net profit of 60.99 Cr in 2025.

The Mutual Fund Shareholding was 6.63% at the end of 31 Dec 2025.